Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Zolazepam

Zolazepam

Zolazepam structure

Zolazepam 

structure
  • CAS No:

    31352-82-6

  • Formula:

    C15H15FN4O

  • Chemical Name:

    Zolazepam

  • Synonyms:

    Pyrazolo[3,4-e][1,4]diazepin-7(1H)-one,4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethyl-;Pyrazolo[3,4-e][1,4]diazepin-7(1H)-one,4-(o-fluorophenyl)-6,8-dihydro-1,3,8-trimethyl-;4-(2-Fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo[3,4-e][1,4]diazepin-7(1H)-one;CI 716;Zolazepam;4-(o-Fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo[3,4-e][1,4]diazepin-7(1H)-one;Flupyrazapon

  • Categories:

    Pharmaceutical Intermediates  >  Bulk Drug Intermediates

Description

Zolazepam is a pyrazolodiazepinone derivative used as an anaesthetic in veterinary medicine. Zolazepam is typically used in combination with the NMDA antagonist tiletamine or the α2 adrenoceptor agonist xylazine. It is around four times the potency of diazepam but it is both water-soluble and un-ionized at physiological pH meaning that its onset is very fast.|A pyrazolodiazepinone with pharmacological actions similar to ANTI-ANXIETY AGENTS. It is commonly used in combination with TILETAMINE to obtain immobilization and anesthesia in animals.

Zolazepam Basic Attributes

286.3

286.30

608-606-2

G1R474U58U

DTXSID30185278

Characteristics

50.5 Ų

1.31±0.1 g/cm3

183-185 °C @ Solvent: Methanol, Diethyl ether

506.6±50.0 °C(Predicted)

1.85±0.20

162.3 Ų [M+H]+ [CCS Type: TW, Method: Major Mix IMS/Tof Calibration Kit (Waters)]

Safety Information

|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Drug Information

Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)|Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)

CI 716

Zolazepam Use and Manufacturing

Uses

A sedative and anesthetic

Pharmaceuticals -> Animal Drugs -> Approved in Taiwan

Computed Properties

Molecular Weight:286.30
XLogP3:1.7
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:1
Exact Mass:286.12298928
Monoisotopic Mass:286.12298928
Topological Polar Surface Area:50.5
Heavy Atom Count:21
Complexity:455
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Zolazepam

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.